Dr Wang Qi holds a Ph.D. in Health Policy (Politics) from McMaster University, along with a Master of Medicine (Integrated Western and Chinese Medicine) and a Bachelor of Medicine (Anesthesiology) from Lanzhou University, China. Dr Wang is the Secretariat Head for the RIGHT Collaboration, member of the GRADE Working Group and Cochrane.

Her research focuses on evidence-informed decision-making in health systems, evidence synthesis methodologies, and health guidelines. Dr Wang has published 80 papers, including in The Lancet, BMJ, and Annals of Internal Medicine. She has contributed to over 10 national and international practice guidelines and participated in more than 40 projects, including WHO guideline implementation, Cochrane Reviews, and the Global Commission on Evidence to Address Societal Challenges.

1. Wei Y, Wang Q, Zhang D. Integrate evidence certainty in ranking interventions. Lancet. 2024 Jul 20;404(10449):239-240. (Impact factor: 98.4 (2023); Ranking: 1 of 329 in Medicine, General & Internal)
2. Wu J, Wang Q, He X. Enhancing the interpretation of continuous outcomes and subgroup analyses in systematic reviews. JAMA Pediatr. 2024 Apr 22. (Impact factor: 24.7 (2023); Ranking: 1 of 186 in Pediatrics)
3. Wang Q, Wu J, Ma Y, Zhu Y, Song X, Xie S, Liang F, Gimzewska M, Li M, Yao L. Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair. Cochrane Database Syst Rev. 2023 Jan 11;1(1):CD010185. (Impact factor: 8.8 (2023); Ranking: 19 of 329 in Medicine, General & Internal)
4. Yao L, Sadeghirad B, Li M, Li J, Wang Q, Crandon HN, Martin G, Morgan R, Florez ID, Hunskaar BS, Wells J, Moradi S, Zhu Y, Ahmed MM, Gao Y, Cao L, Yang K, Tian J, Li J, Zhong L, Couban RJ, Guyatt GH, Agoritsas T, Busse JW. Management of chronic pain secondary to temporomandibular disorders: A systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226. (Impact factor: 93.7 (2023); Ranking: 3 of 329 in Medicine, General & Internal)
5. Xie S, Zhu Y, Wang X, Wu J, Wang Q*. Confidence of evidence should be considered in ranking of treatments in the network meta-analysis. Lancet Psychiatry. 2022 Apr;9(4):e15. (Impact factor: 64.3 (2022); Ranking: 2 of 279 in Psychiatry)
6. Wang Q, Yao L, Chen Y. Combination antidepressant therapy vs monotherapy-further considerations. JAMA Psychiatry. 2022 Aug 1;79(8):831-832. (Impact factor: 25.8 (2022); Ranking: 3 of 279 in Psychiatry)
7. Wang Q, Zhu Y, Xie S, Kibria MG, Guo Q, Belal AA, Li Y, Zhang J, Chen Y, Schünemann HJ, Wilson MG, Yang K, Lavis JN. Facilitators, barriers and strategies for health-system guidance implementation: A critical interpretive synthesis protocol. Health Res Policy Syst. 2022 Sep 29;20(1):105. (Impact factor: 4.0 (2022); Ranking: 13 of 118 in Health Policy & Services)
8. Wang Q, Austvoll-Dahlgren A, Zhang J, Yu Y, Zhou Q, Yang N, Liu L, Chen Y. Evaluating people's ability to assess treatment claims: Validating a test in Mandarin from Claim Evaluation Tools database. J Evid Based Med. 2019 May;12(2):140-146. (Impact factor: 3.6; Ranking: 12 of 310 in Health Policy)
9. Wang Q, Wang X, Chen Y, Yang K. Research gap of guidelines might be an important approach to prioritization (Letter commenting on: J Clin Epidemiol. 2015;68:341-6). J Clin Epidemiol. 2016 Jan;69:251-2. (Impact factor: 4.978 (2016); Ranking: 7 of 174 in Health Care Sciences & Services)